Skip to content

Application of single-port plus one-port laparoscopy in uterine-sparing adenomyosis surgery

Application of single-port plus one-port laparoscopy in uterine-sparing adenomyosis surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058094
Enrollment
Unknown
Registered
2022-03-29
Start date
2022-04-10
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

Experimental group:single-port plus one-port laparoscopic adenomyosis resection

Sponsors

Jiaxing Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients who require to keep their uterus and have no recent fertility requirements and do not want to undergo hysterectomy/drug therapy. 2. The patient was diagnosed as adenomyosis by clinical symptoms, physical examination, ultrasound and MRI, and confirmed as adenomyosis by postoperative pathology. 3. Aged 18-55 years (pre-menopausal). 4. Volunteer to take the test and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Complicated malignancies (including reproductive and other systems); 2. Complicated with fibroids, endometriosis, endometrial polyps and other hormone-dependent diseases; 3. Abnormal development of the umbilical cord; 4. The general condition can not tolerate surgery or anesthesia, such as severe anemia, coagulopathy, pelvic adhesions, etc.; 5. Patients who had participated in other clinical trials or were considered unsuitable for this study by other researchers within 3 months prior to screening; 6. Laboratory test values suggest abnormal clinical significance.

Design outcomes

Primary

MeasureTime frame
Dysmenorrhea;

Secondary

MeasureTime frame
Uterine volume;Operation time;Surgical blood loss;Hospitalization cost;Patient satisfaction;Post-operative recovery;CA125 levels;Menstrual flow;

Countries

China

Contacts

Public ContactChe Xuan

Jiaxing Maternal and Child Health Hospital

che__xuan@163.com+86 13616738016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026